2023-10 |
Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer |
CLINICAL BREAST CANCER
|
2023-07 |
Eflapegrastim versus Pegfilgrastim for Chemotherapy-Induced Neutropenia in Korean and Asian Patients with Early Breast Cancer: Results from the Two Phase III ADVANCE and RECOVER Studies |
CANCER RESEARCH AND TREATMENT
|
2023-01 |
Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09) |
Cancer research and treatment
|
2022-07 |
Usefulness of Hounsfield Units and the Serum Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Patients with Breast Cancer |
Cancers
|
2022-01 |
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations |
CANCER RESEARCH AND TREATMENT
|
2021-12 |
Awareness of Doctors’ Shared Decision-Making in Life-Sustaining Care Decisions |
Journal of Hospice and Palliative Care
|
2021-11 |
Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
2021-10 |
Neutrophil to Lymphocyte Ratio after Treatment Completion as a Potential Predictor of Survival in Patients with Triple-Negative Breast Cancer |
JOURNAL OF BREAST CANCER
|
2021-08 |
Increasing Mortality in Korean Patients With Breast Cancer: High Mortality Rate in Elderly Breast Cancer Population Due to Suboptimal Treatment and Other Diseases |
CANCER CONTROL
|
2021-05 |
2020 Korean guidelines for the management of metastatic prostate cancer |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
2020-03 |
Changes in neutrophil to lymphocyte ratio (NLR) during neoadjuvant treatment correlated with patients' survival |
BREAST CANCER
|
2019-11 |
Tyrosine Kinase Inhibitor Dosing Patterns in Elderly Patients With Chronic Myeloid Leukemia |
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
|
2019-10 |
Sonic Hedgehog Pathway as the Prognostic Marker in Patients with Extensive Stage Small Cell Lung Cancer |
YONSEI MEDICAL JOURNAL
|
2018-03 |
Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee. |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
2016-07 |
Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma |
YONSEI MEDICAL JOURNAL
|
2016-04 |
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative |
ONCOTARGET
|
2016-03 |
Cranofacial osteosarcoma: Single institutional experience in Korea |
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
|
2015-06 |
Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
2015-03 |
Pain Palliation in Patients with Bone Metastases Using Magnetic Resonance-Guided Focused Ultrasound with Conformal Bone System: A Preliminary Report |
YONSEI MEDICAL JOURNAL
|
2014-10 |
Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
2014-09 |
Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma |
JOURNAL OF NEURO-ONCOLOGY
|
2013-12 |
Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancer |
BREAST
|
2013-06 |
Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma |
Cancer Research and Treatment
|
2013-06 |
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer |
LUNG CANCER
|
2012-04 |
Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients |
JOURNAL OF THORACIC ONCOLOGY
|
2012-03 |
Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis |
Cancer Research and Treatment
|